Equity · Healthcare
CVS
NYSECVS Health (CVS)
The line runs 87.85 USD on 28 September through 80.62 USD on 20 November, on a scale from 75 to 95. Days the market did not trade hold the previous close, flat.
- Market cap
- 103.2B USD
- P/E (TTM)
- 9.4
- Revenue, year to Dec 2025
- 402.1B USD
- EPS, diluted, year to Dec 2025
- 1.39 USD
- 52-week range
- 70.08 USD – 110.58 USD
- Avg volume
- 716.2K
- Mentions, 30 days
- 6
- Net sentiment
- +0.07
as of Nov 20, 2026
Have CVS Health (CVS) insiders bought or sold shares recently?
In the 90 days to 23 Nov 2026, CVS Health insiders reported 1 open-market purchase and no sales (SEC Form 4).
Form 4, 90 days to 23 Nov 2026, newest reported trade 6 Nov 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 06 Nov 2026 | Shah Prem SEVP and Group President | Buy | 23,855 | 2.0M USD |
Which funds hold CVS Health (CVS)?
14 of the 45 institutional funds we track reported a CVS Health position for the quarter ended 30 Sep 2026 — a combined 1.0B USD; the latest of those filings landed 16 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| AQR Capital Management | Held (±25%) | 2,936,150 | 251.6M USD | +21.7% |
| Renaissance Technologies | Added | 2,724,053 | 233.4M USD | +517.7% |
| Millennium Management | Trimmed | 1,495,249 | 128.1M USD | −30.9% |
| Glenview Capital Management | Trimmed | 1,278,873 | 109.6M USD | −73.5% |
| D. E. Shaw & Co. | Trimmed | 1,028,148 | 88.1M USD | −25.6% |
| Man Group | Added | 854,768 | 73.2M USD | +277.6% |
| Citadel Advisors | Trimmed | 815,797 | 69.9M USD | −83.0% |
| Bridgewater Associates | Held (±25%) | 378,152 | 32.4M USD | −14.2% |
| Two Sigma Investments | New position | 134,635 | 11.5M USD | |
| Fisher Asset Management | Held (±25%) | 97,886 | 8.4M USD | +6.4% |
Showing the 10 largest of 14 reported positions. The figures above count all of them.
Have members of Congress traded CVS Health (CVS)?
The most recent congressional trade disclosed in CVS Health is a sale by Dwight Evans (house, PA), dated 21 Nov 2025.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 21 Nov 2025 | Dwight Evanshouse · Democrat–PA | Sale | 1K USD–15K USD | 175 days |
| 21 Nov 2025 | Dwight Evanshouse · Democrat–PA | Sale | 1K USD–15K USD | 28 days |
| 31 Oct 2025 | Lisa C. McClainhouse · Republican–MI | Sale | 1K USD–15K USD | 21 days |
| 30 Oct 2025 | Lisa C. McClainhouse · Republican–MI | Sale | 1K USD–15K USD | 22 days |
| 30 Oct 2025 | Lisa C. McClainhouse · Republican–MI | Purchase | 1K USD–15K USD | 22 days |
| 08 Aug 2025 | Adam Smithhouse · Democrat–WA | Sale | 1K USD–15K USD | 0 days |
| 15 May 2025 | Robert P. Bresnahan, Jr.house · Republican–PA | Sale | 1K USD–15K USD | 16 days |
| 01 Apr 2025 | Julie Johnsonhouse · Democrat–TX | Sale | 1K USD–15K USD | 43 days |
CVS Health (CVS) US federal contracts
US federal agencies committed 5.8M USD in contracts to CVS Health (CVS) in fiscal 2026, the year to 30 Sep 2026, against 7.1M USD the year before.
USAspending.gov
| Signed | Agency | Contract | Committed |
|---|---|---|---|
| 25 Sep 2026 | Food and Drug AdministrationDepartment of Health and Human Services | BEST 3 TASK ORDER; HEALTH CARE DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS. EO 14398SPECIAL STUDIES/ANALYSIS- MEDICAL/HEALTH · 75F40126F19003 · CVS HEALTHSPIRE PAYOR & LIFE SCIENCES LLC | 7.0M USD |
| 01 Apr 2026 | Department of Veterans Affairs | PHARMACY MEDICATION REPACKAGING AND DISPENSING SERVICESMEDICAL- OTHER · 36C25926N0296 · SUPERIOR CARE PHARMACY, LLC | 204K USD |
| 29 Sep 2025 | Food and Drug AdministrationDepartment of Health and Human Services | CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) REQUIREMENT FOR BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: HEALTH CARE…SPECIAL STUDIES/ANALYSIS- MEDICAL/HEALTH · 75F40125F19002 · CVS HEALTHSPIRE PAYOR & LIFE SCIENCES LLC | 5.5M USD |
| 24 Sep 2025 | Department of Veterans Affairs | PHARMACY REPACKAGINGMEDICAL- OTHER · 36C25925P0636 · SUPERIOR CARE PHARMACY, LLC | 200K USD |
| 20 May 2025 | Food and Drug AdministrationDepartment of Health and Human Services | CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) REQUIREMENT FOR BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: HEALTH CARE…SPECIAL STUDIES/ANALYSIS- MEDICAL/HEALTH · 75F40125F19001 · CVS HEALTHSPIRE PAYOR & LIFE SCIENCES LLC | 1.4M USD |
| 29 Jul 2024 | Department of Veterans Affairs | PHARMACEUTICAL DOSESMEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES · 36C25524P0492 · PROCARE PHARMACY DIRECT, L.L.C. | 329K USD |
Contracts of US$100,000 or more signed since April 2022; the amount is what the government has committed so far, which grows when options are exercised. Defense Department contracts are published about 90 days after signing, so the latest year is still filling in.
What has been filed or recorded for CVS Health (CVS)?
The filings we hold for CVS Health, newest first: 5 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 28 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 28 Oct 2026 | Fails to deliver | Shares failed to deliver | 27 shares | 2K USD notional · <0.001% of shares out |
| 26 Oct 2026 | Fails to deliver | Shares failed to deliver | 116 shares | 11K USD notional · <0.001% of shares out |
| 23 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,695 shares | 160K USD notional · <0.001% of shares out |
| 22 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,200 shares | 112K USD notional · <0.001% of shares out |
| 20 Oct 2026 | Fails to deliver | Shares failed to deliver | 1 shares | 93 USD notional · <0.001% of shares out |
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 1.68 USD | Revenue $108.40B |
| 30 Sep 2026 | Financials | Total assets | 258.1B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 80.5B USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 2.31 USD | Revenue $106.10B |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 2.30 USD | Revenue $100.43B |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 1.39 USD | Revenue $402.07B |
| 31 Dec 2025 | Financials | Revenue | 402.1B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 1.8B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 1.39 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −3.13 USD | Revenue $102.87B |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.80 USD | Revenue $98.92B |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 1.41 USD | Revenue $94.59B |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 3.66 USD | Revenue $372.81B |
What is Reddit saying about CVS Health (CVS)?
Reddit mentioned CVS 6 times in the 30 days to 22 November 2026, across 2 of the communities we track. All of them were scored for sentiment: 67% read bullish, 0% bearish and 33% neither. Reddit data updated 22 November 2026.
30-day window, Method
How do Reddit mentions of CVS Health (CVS) compare with its price?
Share ↗
Which subreddits are talking about CVS Health (CVS)?
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 83% | 5 | +0.08 |
| r/stocks | 17% | 1 | +0.00 |
What do people ask about CVS Health (CVS)?
What did CVS Health shares close at?80.62
CVS Health closed at 80.62 USD on 20 Nov 2026, up 0.69% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is CVS Health’s market cap?103.2B
CVS Health is worth 103.2B USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.
What is CVS Health’s P/E ratio?9.4
CVS Health has a price-to-earnings ratio of 9.4, as of 20 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is CVS Health’s revenue?402.1B
CVS Health reported revenue of 402.1B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have CVS Health insiders bought or sold shares recently?1 purchase
In the 90 days to 23 Nov 2026, CVS Health insiders reported 1 open-market purchase and no sales (SEC Form 4). See Insiders
Which funds own CVS Health?14 of 45
14 of the 45 funds we track reported a CVS Health position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were AQR Capital Management, Renaissance Technologies and Millennium Management. See Funds
Have members of Congress traded CVS Health?57 trades
Yes. 57 trades in CVS Health appear in the congressional disclosures we hold; the latest is a sale by Dwight Evans (House, PA) dated 21 Nov 2025, filed 15 May 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did CVS Health last report earnings?1.68
CVS Health last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 1.68 USD; no next date is announced in SEC filings yet. See Filings
Does CVS Health have government contracts?5.8M
Yes. US federal agencies committed 5.8M USD in contracts to it in fiscal 2026, the year to 30 Sep 2026 (USAspending.gov). See Contracts
What is Reddit saying about CVS Health?2 mentions
CVS Health was mentioned 2 times in the last 7 days across the finance subreddits we track, and 6 times over the trailing 30 days. Of the 6 mentions scored for sentiment, 67% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- Wikimedia CommonsPortraits via Wikimedia Commons. Lisa C. McClain: Office of Congresswoman Lisa McClain, Public domain; Adam Smith: Unknown authorUnknown author, Public domain; Robert P. Bresnahan, Jr.: House Creative Services, Public domain; Dwight Evans: Dwight Evans for Mayor, CC BY 2.0.
- House disclosuresU.S. House of Representatives financial disclosures
- USAspendingUSAspending.gov (U.S. Department of the Treasury), federal prime contract awards
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings
- SEC filingAbout text: the company's latest annual report filed with the SEC (Business section), summarised in our own words